Trademark: 86918014
Status Date
Friday, January 19, 2024
Registration Number
5330434
Registration Date
Tuesday, November 7, 2017
Filing Date
Wednesday, February 24, 2016
Published for Opposition
Tuesday, July 12, 2016
5 Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders
42 Pharmaceutical products development; pharmaceutical product evaluation; pharmaceutical research services; medical and scientific research, namely, conducting clinical trials for others
Jan 19, 2024
Notice Of Acceptance Of Sec. 8 - E-Mailed
Jan 19, 2024
Registered - Sec. 8 (6-Yr) Accepted
Jan 19, 2024
Case Assigned To Post Registration Paralegal
Nov 6, 2023
Teas Section 8 Received
Nov 7, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Nov 7, 2017
Registered-Principal Register
Oct 4, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 3, 2017
Allowed Principal Register - Sou Accepted
Sep 16, 2017
Statement Of Use Processing Complete
Aug 29, 2017
Use Amendment Filed
Sep 14, 2017
Case Assigned To Intent To Use Paralegal
Aug 29, 2017
Teas Statement Of Use Received
Mar 8, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 6, 2017
Sou Extension 1 Granted
Mar 6, 2017
Sou Extension 1 Filed
Mar 6, 2017
Sou Teas Extension Received
Sep 6, 2016
Noa E-Mailed - Sou Required From Applicant
Jul 12, 2016
Official Gazette Publication Confirmation E-Mailed
Jul 12, 2016
Published For Opposition
Jun 22, 2016
Notification Of Notice Of Publication E-Mailed
Jun 8, 2016
Approved For Pub - Principal Register
Jun 8, 2016
Assigned To Examiner
Mar 10, 2016
Teas Change Of Correspondence Received
Mar 1, 2016
Notice Of Pseudo Mark E-Mailed
Feb 29, 2016
New Application Office Supplied Data Entered
Feb 27, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
